Kaletra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection
Condition:   SARS-CoV 2 Interventions:   Biological: Hyperimmune plasma;   Drug: Hidroxicloroquina + Azitromicina o Lopinavir/ritonavir + Interferon β-1b + Hidroxicloroquina Sponsor:   Andalusian Network for Design and Translation of Advanced Therapies Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2020 Category: Research Source Type: clinical trials